SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene

Journal of Cellular Biochemistry

Volumn 114, Issue 3, 2013, Pages 589-598

  Wang, Chiung Min ^a   Brennan, Victoria C ^a   Gutierrez, Ninoska M ^a   Wang, Xirui ^a   Wang, Lizhong ^b   Yang, Wei Hsiung ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ATF3; p53, TRANSCRIPTIONAL ACTIVITY; SUMOylation

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; LYSINE; PROTEIN; PROTEIN P53; RECOMBINANT PROTEIN; SENP2 PROTEIN; SENP7 PROTEIN; SUMO E2 PROTEIN; SUMO PROTEIN; UBE2I PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SUMOYLATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; GENES, P53; HEK293 CELLS; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MUTATION; NEOPLASMS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 84872785392     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24396     Document Type: Article

References (49)

1. Abed M, Barry KC, Kenyagin D, Koltun B, Phippen TM, Delrow JJ, Parkhurst SM, Orian A,. 2011. Degringolade, a SUMO-targeted ubiquitin ligase, inhibits Hairy/Groucho-mediated repression. EMBO J 30: 1289-1301.
2. Campbell LA, Faivre EJ, Show MD, Ingraham JG, Flinders J, Gross JD, Ingraham HA,. 2008. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol Cell Biol 28: 7476-7486.
3. Castillo-Lluva S, Tatham MH, Jones RC, Jaffray EG, Edmondson RD, Hay RT, Malliri A,. 2010. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat Cell Biol 12: 1078-1085.
4. Chun TH, Itoh H, Subramanian L, Iñiguez-Lluhí JA, Nakao K,. 2003. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy. Circ Res 92: 1201-1208.
5. Dou H, Huang C, Singh M, Carpenter PB, Yeh ET,. 2010. Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. Mol Cell 39: 333-345.
6. Duverger O, Chen SX, Lee D, Li T, Chock PB, Morasso MI,. 2011. SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity. J Cell Biochem 112: 445-452.
7. Finkbeiner E, Haindl M, Muller S,. 2011. The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex. EMBO J 30: 1067-1078.
8. Gill G,. 2005. Something about SUMO inhibits transcription. Curr Opin Genet Dev 15: 536-541.
9. Gong Z, Brackertz M, Renkawitz R,. 2006. SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex. Mol Cell Biol 26: 4519-4528.
10. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G,. 1999. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18: 6462-6471.
11. Guo B, Yang SH, Witty J, Sharrocks AD,. 2007. Signalling pathways and the regulation of SUMO modification. Biochem Soc Trans 35: 1414-1418.
12. Grünwald M, Bono F,. 2011. Structure of Importin13-Ubc9 complex: Nuclear import and release of a key regulator of sumoylation. EMBO J 30: 427-438.
13. Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M,. 2011. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 8: 19.
14. Hai T, Wolfgang CD, Marsee DK, Allen AE, Silvapresad U,. 1999. ATF3 and stress responses. Gene Exp 7: 312-335.
15. Hamard PJ, Boyer-Guittaut M, Camuzeaux B, Dujardin D, Hauss C, Oelgeschläger T, Vigneron M, Kedinger C, Chatton B,. 2007. Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity. Nucleic Acids Res 35: 1134-1144.
16. Huang X, Li X, Guo B,. 2008. KLF6 induces in prostate cancer cells through up-regulation of ATF3. J Biol Chem 283: 29795-29801.
17. Johnson ES,. 2004. Protein modification by SUMO. Annu Rev Biochem 73: 355-382.
18. Kawai T, Akira S,. 2006. TLR signaling. Cell Death Differ 13: 816-825.
19. Kawauchi J, Zhang C, Nobori K, Hashimoto Y, Adachi MT, Noda A, Sunamori M, Kitajima S,. 2002. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 277: 39025-39034.
20. Kubota Y, O'Grady P, Saito H, Takekawa M,. 2011. Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation. Nat Cell Biol 13: 282-291.
21. Liu W, Iiizumi-Gairani M, Okuda H, Kobayashi A, Watabe M, Pai SK, Pandey PR, Xing F, Fukuda K, Modur V, Hirota S, Suzuki K, Chiba T, Endo M, Sugai T, Watabe K,. 2011. KAI1 Gene Is Engaged in NDRG1 Gene-mediated Metastasis Suppression through the ATF3-NF{kappa}B Complex in Human Prostate Cancer. J Biol Chem 286: 18949-18959.
22. Lim JH, Lee HJ, Pak YK, Kim WH, Song J,. 2011. Organelle stress-induced activating transcription factor-3 downregulates low-density lipoprotein receptor expression in Sk-Hep1 human liver cells. Biol Chem 392: 377-385.
23. Ling Y, Sankpal UT, Robertson AK, McNally JG, Karpova T, Robertson KD,. 2004. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acid Res 32: 598-610.
24. Lu D, Wolfgang CD, Hai T,. 2006. Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem 281: 10473-10481.
25. Martin S, Wilkinson KA, Nishimune A, Henley JM,. 2007. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci 8: 948-959.
26. Melchior F,. 2000. SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol 16: 591-626.
27. Mo P, Wang H, Lu H, Boyd DD, Yan C,. 2010. MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem 285: 26908-26915.
28. Mukhopadhyay D, Dasso M,. 2007. Modification in reverse: The SUMO proteases. Trends Biochem Sci 32: 286-295.
29. Nagai S, Davoodi N, Gasser SM,. 2011. Nuclear organization in genome stability: SUMO connections. Cell Res 21: 474-485.
30. Pebernard S, Schaffer L, Campbell D, Head SR, Boddy MN,. 2008. Localization of Smc5/6 to centromeres and telomeres requires heterochromatin and SUMO, respectively. EMBO J 27: 3011-3023.
31. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT,. 1999. SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
32. Rytinki MM, Palvimo JJ,. 2008. SUMOylation modulates the transcription repressor function of RIP140. J Biol Chem 283: 11586-11595.
33. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R,. 2001. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev 15: 3088-3103.
34. Saitoh H, Hinchey J,. 2000. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275: 6252-6258.
35. Suda N, Shibata H, Kurihara I, Ikeda Y, Kobayashi S, Yokota K, Murai-Takeda A, Nakagawa K, Oya M, Murai M, Rainey WE, Saruta T, Itoh H,. 2011. Coactivation of SF-1-Mediated Transcription of Steroidogenic Enzymes by Ubc9 and PIAS1. Endocrinology 152: 2266-2277.
36. Sydorskyy Y, Srikumar T, Jeram SM, Wheaton S, Vizeacoumar FJ, Makhnevych T, Chong YT, Gingras AC, Raught B,. 2010. A novel mechanism for SUMO system control: Regulated Ulp1 nucleolar sequestration. Mol Cell Biol 30: 4452-4462.
37. Takahashi Y, Lallemand-Breitenbach V, Zhu J, de Thé H,. 2004. PML nuclear bodies and apoptosis. Oncogene 23: 2819-2824.
38. Wang XD, Lapi E, Sullivan A, Ratnayaka I, Goldin R, Hay R, Lu X,. 2011. SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence. Cell Death Differ 18: 304-314.
39. Wilkinson KA, Henley JM,. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J 428: 133-145.
40. Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K, Hofbauer GF, Dotto GP,. 2010. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465: 368-372.
41. Yamamoto H, Ihara M, Matsuura Y, Kikuchi A,. 2003. SUMOylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J 22: 2047-2059.
42. Yan C, Lu D, Hai T, Boyd DD,. 2005. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 24: 2425-2435.
43. Yan L, Della Coletta L, Powell KL, Shen J, Thames H, Aldaz CM, MacLeod MC,. 2011. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors. PLoS One 6: e16515.
44. Yan S, Sun X, Xiang B, Cang H, Kang X, Chen Y, Li H, Shi G, Yeh ET, Wang B, Wang X, Yi J,. 2010. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J 29: 3773-3786.
45. Yang WH, Heaton JH, Brevig H, Mukherjee S, Iñiguez-Lluhí JA, Hammer GD,. 2009. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Mol Cell Biol 29: 613-625.
46. Yin X, DeWille JW, Hai T,. 2008. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 27: 2118-2127.
47. Yoshida T, Sugiura H, Mitobe M, Tsuchiya K, Shirota S, Nishimura S, Shiohira S, Ito H, Nobori K, Gullans SR, Akiba T, Nitta K,. 2008. ATF3 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 19: 217-224.
48. Zhong S, Müller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP,. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748-2752.
49. Zhou H, Shen DF, Bian ZY, Zong J, Deng W, Zhang Y, Guo YY, Li H, Tang QZ,. 2011. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload. PLoS One 6: e26744.